UnitedHealth Group Incorporated
UNH
$491.91
$5.861.21%
| Weiss Ratings | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Excellent | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Reward Grade | A- | |||
| Rating Factors | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.44 | |||
| Price History | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.56% | |||
| 30-Day Total Return | -8.63% | |||
| 60-Day Total Return | -9.84% | |||
| 90-Day Total Return | -5.62% | |||
| Year to Date Total Return | -5.15% | |||
| 1-Year Total Return | 6.89% | |||
| 2-Year Total Return | 49.40% | |||
| 3-Year Total Return | 79.64% | |||
| 5-Year Total Return | 113.93% | |||
| 52-Week High % Change | -12.91% | |||
| 52-Week Low % Change | 9.04% | |||
| Price | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $558.10 | |||
| 52-Week Low Price | $445.74 | |||
| 52-Week Low Price (Date) | Feb 24, 2022 | |||
| 52-Week High Price (Date) | Oct 31, 2022 | |||
| Valuation | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | $454.14B | |||
| Enterprise Value | 493.30B | |||
| Price/Earnings (TTM) | 23.80 | |||
| Earnings Per Share (TTM) | 20.42 | |||
| Earnings Per Share Growth | 26.69% | |||
| Price/Earnings To Growth | 0.89 | |||
| Price/Sales (TTM) | 1.46 | |||
| Price/Book (Q) | 6.09 | |||
| Enterprise Value/Revenue (TTM) | 1.57 | |||
| Price | $491.92 | |||
| Enterprise Value/EBITDA (TTM) | 16.29 | |||
| Enterprise Value/EBIT | 18.21 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 948.000M | |||
| Dividend Yield | 1.32% | |||
| Div. Per Share (Most Recent) | $1.65 | |||
| Dividend Per Share (TTM) | $6.40 | |||
| Payout Ratio (TTM) | 29.93% | |||
| Dividend Per Share (Most Recent) | $1.65 | |||
| Company Info | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 952 936 1300 | |||
| Address | UnitedHealth Group Center Minnetonka, MN 55343 | |||
| Website | www.unitedhealthgroup.com | |||
| Country | United States | |||
| Year Founded | 1977 | |||
| Profitability | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 8.59% | |||
| Profit Margin | 6.16% | |||
| Management Effectiveness | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.42% | |||
| Return on Equity | 25.29% | |||
| Income Statement | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | $288.98B | |||
| Total Revenue (TTM) | $315.12B | |||
| Revenue Per Share | $332.40 | |||
| Gross Profit (TTM) | $76.32B | |||
| EBITDA (TTM) | $30.27B | |||
| EBIT (TTM) | $27.09B | |||
| Net Income (TTM) | $19.43B | |||
| Net Income Avl. to Common (TTM) | $19.43B | |||
| Total Revenue Growth (Q YOY) | 11.83% | |||
| Earnings Growth (Q YOY) | 28.47% | |||
| EPS Diluted (TTM) | $20.42 | |||
| EPS Diluted Growth (Q YOY) | 29.67% | |||
| Balance Sheet | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $42.53B | |||
| Cash Per Share (Q) | $44.86 | |||
| Total Current Assets (Q) | $78.92B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | $82.92B | |||
| Current Ratio (Q) | 0.782 | |||
| Book Value Per Share (Q) | $79.80 | |||
| Total Assets (Q) | $243.06B | |||
| Total Current Liabilities (Q) | $100.94B | |||
| Total Debt (Q) | $48.67B | |||
| Total Liabilities (Q) | $160.14B | |||
| Total Common Equity (Q) | $74.65B | |||
| Cash Flow | UNH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$12.39B | |||
| Cash from Financing (TTM) | -$3.79B | |||
| Net Change in Cash (TTM) | $17.76B | |||
| Levered Free Cash Flow (TTM) | $34.74B | |||
| Cash from Operations (TTM) | $33.96B | |||
